DrCheema.com is a professional healthcare website dedicated to providing expert medical advice, wellness consultations, and patient care resources. Our team at Marketions was entrusted with designing and developing a modern WordPress website that enhances online accessibility and delivers a seamless user experience for patients seeking medical guidance.

Project Scope & Features

 

  • To align with Dr. Cheema’s medical expertise and patient-centric approach, we focused on:
  • Custom WordPress Design & Development – Created a clean, professional, and user-friendly website tailored to medical services.
  • Online Appointment & Consultation Booking – Integrated a hassle-free scheduling system, allowing patients to book consultations easily.
  • Service Pages & Medical Information Hub – Developed comprehensive sections detailing healthcare services, treatment options, and patient education.
  • SEO & Performance Optimization – Implemented advanced SEO techniques to boost search rankings and attract organic traffic.
  • Mobile-Responsive & Fast-Loading Design – Ensured an optimized experience across all devices, enhancing accessibility and usability.
firefox_2025-04-24_01-04-18
firefox_2025-04-24_01-04-59

Impact & Results

 

With the newly designed website, DrCheema.com has significantly improved patient engagement, making it easier for visitors to access medical information and book services. The SEO-optimized structure has enhanced search engine visibility, driving more traffic and patient inquiries. By offering a professional, informative, and user-friendly digital presence, the website strengthens Dr. Cheema’s reputation as a trusted medical professional.

For the fiscal year ended May 31, 2005, revenues increased 12 percent to $13.7 billion, compared to $12.3 billion in fiscal year 2004. Changes in currency exchange rates contributed three percentage points of this growth, while the acquisition of Converse and Starter added one point. Full year net income was up 28 percent to $1.2 billion, or $4.48 per diluted share, versus $945.6 million, or $3.51 per diluted share, in 2004.